Neural Tube Defects

Slide 1 · Neural Tube Defects

Developmental mechanisms · Morphology · Clinicopathologic consequences

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning outcomes

Explain the two distinct developmental pathways to neural tube defects.

Classify lesions by site and by whether meninges or neural tissue is displaced.

Connect structural abnormalities to neurologic effects and infection risk.

Describe the evidence and timing of folate-related prevention.

Slide 3 · Neural tube defects are midline malformations

Neural tissue, meninges, overlying bone and soft tissue may be affected together.

These abnormalities form the most common group of CNS malformations.

The physical lesion is often a combination of defects rather than an isolated one.

Overlying soft tissue / skin

Bone / vertebral arch or calvarium

Meninges

Neural tissue

Any combination may be malformed

Slide 4 · Why the tissue layers must be considered together

A surface defect may conceal involvement of the meninges or nervous tissue.

A bony defect does not, by itself, specify what is present in a protruding sac.

Morphologic naming is based on the affected anatomic compartments.

Meninges

Neural tissue

Bone / skin

Which compartment is abnormal?

Slide 5 · Two developmental routes converge on midline defects

Route 1: Neural tube closure fails; Skeletal abnormalities develop secondarily.

Route 2: Abnormal axial mesoderm produces a primary bony defect.

Both routes can lead to composite CNS and supporting-tissue malformations.

Developmental defect

Neural tube does not close

Axial mesoderm / bone defect

Secondary skeletal abnormality

Secondary CNS abnormality

Slide 6 · Neural tube closure failure: The primary event

A malformed neural tube is the initial developmental abnormality.

Aberrant skeletal modeling develops around the malformed tube.

Anencephaly and myelomeningocele are the textbook examples.

Failure of tube closure

Malformed neural axis

Abnormal skeletal modeling around tube

Slide 7 · Primary mesodermal defect: The alternative route

An abnormal axial mesoderm disrupts formation of the bony midline.

Neural structures are then affected secondarily by the skeletal defect.

Encephalocele, meningocele and spina bifida illustrate this pathway.

Abnormal axial mesoderm

Primary defect in bone

Secondary neural tissue abnormality

Slide 8 · Mechanism comparison: What fails first?

Feature

Neural closure failure

Primary skeletal defect

Initial problem

Closure of neural tube

Axial mesoderm / bone development

Secondary abnormality

Skeletal modeling

CNS structures

Robbins examples

Anencephaly; Myelomeningocele

Encephalocele; Meningocele; Spina bifida

Slide 9 · The same surface site may imply different lesion contents

External location helps orient the defect but does not fully classify it.

Both may contain meninges; Myelomeningocele additionally contains spinal cord.

A sac containing cord parenchyma establishes neural tissue involvement.

Outpouching through skeletal defect

Meninges only

MENINGOCELE

Meninges + cord

MYELOMENINGOCELE

Contents, not external silhouette, determine name

Slide 10 · Start classification with anatomy—not a label

First localize the defect: Cranial or vertebral midline.

Then identify involved bone, meninges, neural tissue and skin.

Finally, interpret clinical dysfunction according to the involved neural level.

Where is the bony defect?

What tissue extends through it?

Which functional systems are affected?

Slide 11 · Cranial and spinal defects share a developmental theme

Cranial forms involve calvarial and brain relationships.

Spinal forms involve vertebral arches, meninges and spinal cord.

The common denominator is an abnormal midline developmental interface.

Midline developmental malformation

Cranial

Calvarium

Spinal

Vertebral column

Identify site, bone, meninges, neural tissue

Slide 12 · Anatomic vocabulary controls the diagnosis

-cele denotes an outpouching or protrusion in the named lesions.

Meninges refer to protective coverings; Myelo- identifies spinal neural tissue.

Encephalo- identifies brain tissue, allowing meaningful differentiation.

Defect / sac observation

Determine meninges vs neural tissue

Assign precise morphologic term

Slide 13 · Major neural tube defect phenotypes

Anencephaly: Major absence of brain and calvarium.

Myelomeningocele and meningocele: Spinal meningeal / neural extrusion.

Encephalocele: Brain tissue through a cranial defect.

Spina bifida: Broad spinal dysraphism spectrum.

Slide 14 · Anencephaly begins at the anterior neural tube

A defect in anterior neural tube development disrupts formation of the forebrain.

This disruption at approximately day 28 of gestation.

The resulting pathology involves both neural structures and calvarium.

Anterior neural tube malformation

Most brain + calvarium absent

Area cerebrovasculosa remains

Slide 15 · Anencephaly: The defining gross anatomy

Most of the brain is absent.

Most of the cranial vault (calvarium) is absent.

A flattened remnant of disorganized tissue remains rather than a developed forebrain.

Anterior neural tube malformation

Most brain + calvarium absent

Area cerebrovasculosa remains

Slide 16 · Area cerebrovasculosa: The residual tissue

The residual flattened tissue is termed the area cerebrovasculosa.

It is disorganized rather than a normally laminated cortical structure.

Its cellular admixture supports the diagnosis of a disrupted developmental field.

Disorganized remnant

Ependymal elements

Choroid plexus elements

Meningothelial elements

Slide 17 · Area cerebrovasculosa is histologically heterogeneous

Ependymal elements may be present in the remnant.

Choroid plexus components may be admixed.

Meningothelial cells are also described.

The combination is not equivalent to a formed cerebral hemisphere.

Disorganized remnant

Ependymal elements

Choroid plexus elements

Meningothelial elements

Slide 18 · Posterior fossa preservation may vary in anencephaly

Posterior fossa structures are not uniformly absent.

Their preservation depends on the extent of the cranial defect.

Thus, the term anencephaly does not mean all intracranial structures are invariably missing.

Midline developmental malformation

Cranial

Calvarium

Spinal

Vertebral column

Identify site, bone, meninges, neural tissue

Slide 19 · The missing forebrain also means missing connections

Descending tracts arising from disrupted structures are absent.

Structural loss therefore extends beyond the visible brain remnant.

Functional expectations must follow the anatomy that did not develop.

Failure of tube closure

Malformed neural axis

Abnormal skeletal modeling around tube

Slide 20 · Morphologic checklist for recognizing anencephaly

Anterior neural tube developmental abnormality.

Loss of most brain substance and calvarium.

Residual disorganized area cerebrovasculosa.

Variable preservation of posterior fossa structures.

Slide 21 · Myelomeningocele: Spinal cord tissue in the sac

Spinal cord parenchyma protrudes through a defect in the vertebral column.

The meningeal covering accompanies the neural tissue.

The neural component distinguishes myelomeningocele from meningocele.

Outpouching through skeletal defect

Meninges only

MENINGOCELE

Meninges + cord

MYELOMENINGOCELE

Contents, not external silhouette, determine name

Slide 22 · The neural component is diagnostically decisive

Do not equate every lumbosacral sac with myelomeningocele.

Identify whether cord tissue is incorporated in the protruding structure.

A meningeal sac without spinal cord protrusion is termed meningocele.

Neural tissue

Meningeal covering

Schematic representation of sac contents

Slide 23 · Myelomeningoceles favor the lumbosacral region

The lumbosacral region as the commonest site.

The location places developing spinal neural structures at risk.

Level and tissue involvement help explain downstream neurologic deficits.

Occipital

Encephalocele

Nasofrontal

Encephalocele variant

Lumbosacral

Myelomeningocele

Sites stated

Slide 24 · Motor impairment follows spinal cord involvement

Affected individuals can have lower-extremity motor deficits.

The deficit is a neural consequence of the malformed spinal cord.

The external sac is therefore not merely a superficial skin abnormality.

Spinal cord included in defect

Motor / Lower limbs

Sensory / Lower limbs

Bowel / Control

Bladder / Control

Functional effects

Slide 25 · Sensory loss is another consequence of neural injury

Myelomeningocele may affect lower-extremity sensation.

Motor and sensory abnormalities may coexist.

Assessing both domains is necessary to characterize the neurologic burden.

Spinal cord included in defect

Motor / Lower limbs

Sensory / Lower limbs

Bowel / Control

Bladder / Control

Functional effects

Slide 26 · Bowel dysfunction reflects spinal involvement

Disturbed bowel control is a recognized manifestation.

This consequence may accompany limb motor or sensory findings.

The lesion has functional effects beyond the visible anatomic defect.

Spinal cord included in defect

Motor / Lower limbs

Sensory / Lower limbs

Bowel / Control

Bladder / Control

Functional effects

Slide 27 · Bladder dysfunction is a core clinical consequence

Disturbed bladder control accompanies many myelomeningoceles.

Bowel and bladder dysfunction should be evaluated together.

Morphologic involvement of spinal cord tissue explains why pelvic organ function is affected.

Spinal cord included in defect

Motor / Lower limbs

Sensory / Lower limbs

Bowel / Control

Bladder / Control

Functional effects

Slide 28 · Barrier failure explains susceptibility to infection

The overlying skin may be thin and insufficient as a barrier.

Defective barrier function allows vulnerability of exposed spinal tissues.

Superimposed spinal cord infection.

Thin overlying skin

Defective protective barrier

Risk of superimposed spinal cord infection

Slide 29 · Neural loss and infection are distinct injury pathways

Congenital malformation accounts for neurologic abnormalities present with the defect.

Infection is a potential superimposed complication of poor tissue coverage.

Distinguishing primary from secondary injury clarifies clinicopathologic interpretation.

Thin overlying skin

Defective protective barrier

Risk of superimposed spinal cord infection

Slide 30 · Myelomeningocele: Integrated clinical profile

Most commonly located in the lumbosacral region.

Spinal cord parenchyma extends through a vertebral defect.

Lower-limb motor and sensory abnormalities may occur.

Bowel, bladder and infectious complications are clinically important.

Slide 31 · Meningocele: The meninges protrude without cord tissue

The defining extrusion consists of meninges.

A bony defect permits the sac to extend outside its usual compartment.

The absence of cord tissue from the sac is the key morphologic contrast.

Outpouching through skeletal defect

Meninges only

MENINGOCELE

Meninges + cord

MYELOMENINGOCELE

Contents, not external silhouette, determine name

Slide 32 · Meningocele versus myelomeningocele

Criterion

Meningocele

Myelomeningocele

Structure protruding

Meninges

Meninges plus spinal cord parenchyma

Underlying bone

Defect present

Vertebral defect present

Definitional contrast

No cord in sac

Cord tissue in sac

Clinical manifestations in excerpt

Not individually specified

Lower-limb and sphincter deficits; Infection risk

Slide 33 · What can be inferred from a sac—and what cannot?

A protruding sac establishes a structural abnormality but not all its contents.

Neural tissue must be identified to name the lesion precisely.

The appearance alone does not quantify a patient’s neurologic deficits.

Defect / sac observation

Determine meninges vs neural tissue

Assign precise morphologic term

Slide 34 · Case: A protruding sac at the lower back

A newborn has a midline lumbosacral cyst-like lesion. The clinical description does not say whether the cord enters the sac.

Can the lesion already be classified as myelomeningocele?

Examine the structure or clinical clue

Name the lesion and justify why

Slide 35 · Case interpretation: Tissue content resolves the term

No: Lumbosacral position alone does not establish myelomeningocele.

Meninges alone support meningocele.

Extension of cord parenchyma establishes myelomeningocele.

Outpouching through skeletal defect

Meninges only

MENINGOCELE

Meninges + cord

MYELOMENINGOCELE

Contents, not external silhouette, determine name

Slide 36 · Encephalocele: Brain tissue through a cranial defect

Malformed brain tissue protrudes through a midline opening of the cranium.

This is a cranial rather than vertebral extrusion.

The involved tissue is cerebral, rather than simply meningeal.

Midline developmental malformation

Cranial

Calvarium

Spinal

Vertebral column

Identify site, bone, meninges, neural tissue

Slide 37 · Occipital location is most frequent for encephalocele

The typical site is the occiput.

The crucial morphologic feature is the midline skull defect with brain tissue extrusion.

Site and contents should be stated together in a pathology description.

Occipital

Encephalocele

Nasofrontal

Encephalocele variant

Lumbosacral

Myelomeningocele

Sites stated

Slide 38 · Nasofrontal encephalocele: A less typical location

Variants may involve the orbit, ethmoid region or cribriform plate.

These anterior defects belong to the encephalocele spectrum.

Cranial midline localization prevents confusion with spinal dysraphism.

Occipital

Encephalocele

Nasofrontal

Encephalocele variant

Lumbosacral

Myelomeningocele

Sites stated

Slide 39 · Nasal glial heterotopia: The naming pitfall

Robbins mentions nasal glial heterotopia in the nasofrontal variant discussion.

The colloquial term “nasal glioma” may mislead because it implies a neoplasm.

Retain the developmental-malformation context when interpreting this name.

Defect / sac observation

Determine meninges vs neural tissue

Assign precise morphologic term

Slide 40 · Cranial sac lesions versus spinal sac lesions

Feature

Encephalocele

Myelomeningocele

Defect in

Cranium

Vertebral column

Neural component

Malformed brain tissue

Spinal cord tissue

Common location

Occipital

Lumbosacral

General classification

Cranial midline malformation

Spinal dysraphism phenotype

Slide 41 · Spinal dysraphism is a spectrum, not one morphology

Robbins treats spina bifida and spinal dysraphism as a range of defects.

At one end lies asymptomatic spina bifida occulta.

At the severe end, a malformed segment of cord accompanies meningeal outpouching.

Spina bifida occulta

Bone defect, no stated symptoms

Meningocele

Meninges extend outward

Myelomeningocele

Cord tissue in lesion

Severe spinal dysraphism

Flattened, disorganized cord

Slide 42 · Spina bifida occulta: A bony defect may be silent

The occulta form may produce no symptoms.

A bony abnormality alone need not equal severe spinal cord dysplasia.

Morphologic severity cannot be assigned from the label “spina bifida” alone.

Spina bifida occulta

Bone defect, no stated symptoms

Meningocele

Meninges extend outward

Myelomeningocele

Cord tissue in lesion

Severe spinal dysraphism

Flattened, disorganized cord

Slide 43 · Severe dysraphism: Disorganized spinal cord

A segment of spinal cord can be flattened and disorganized.

An overlying meningeal outpouching may accompany the cord defect.

This end of the spectrum differs fundamentally from an isolated silent bony defect.

Spina bifida occulta

Bone defect, no stated symptoms

Meningocele

Meninges extend outward

Myelomeningocele

Cord tissue in lesion

Severe spinal dysraphism

Flattened, disorganized cord

Slide 44 · The spinal spectrum links structure and function

Morphology

What it establishes

Source-supported clinical implication

Isolated bony defect (occulta)

Skeletal midline abnormality

May be asymptomatic

Meningeal extrusion

Coverings displaced

Individual deficits not specified in source

Cord within sac

Neural parenchyma involved

Motor, sensory, bowel and bladder deficits

Thin overlying skin

Incomplete protective barrier

Risk of infection

Slide 45 · A structured description improves classification

Identify the anatomic level and whether it is cranial or spinal.

State whether bone, meninges and neural parenchyma are affected.

Record any skin barrier abnormality and neurologic manifestations.

Where is the bony defect?

What tissue extends through it?

Which functional systems are affected?

Slide 46 · Developmental malformations have mixed influences

Robbins’ parent section identifies both genetic and environmental influences.

Genomic variants are being uncovered for multiple CNS malformations.

Causation for many observed gene–malformation associations remains under investigation.

Genetic factors

Environmental factors

CNS developmental malformations

Specific causal links remain under study

Slide 47 · Folate deficiency is a well-established risk factor

Insufficient folate during the earliest weeks of gestation increases neural tube defect risk.

Folate supplementation reduces—but does not abolish—the risk.

This supports prevention before or very early in pregnancy.

Early gestational folate status

Risk of a neural tube defect

Supplementation reduces risk

Slide 48 · The closure timetable explains prevention timing

Normal neural tube closure is complete by about embryonic day 28.

Many pregnancies have not yet been recognized at that stage.

Starting preventive supplementation only after recognition may miss the critical period.

Embryonic development

Early gestation

Day 28:

Closure normally complete

Risk-sensitive window precedes pregnancy recognition

Slide 49 · Folate prevention is a preconception issue

Supplementation throughout reproductive years.

The rationale is to ensure availability before neural tube closure.

The recommendation follows from embryologic timing rather than from an identified lesion at birth.

Embryonic development

Early gestation

Day 28:

Closure normally complete

Risk-sensitive window precedes pregnancy recognition

Slide 50 · Risk reduction is not the same as complete prevention

Folate status is important, but not the only contributory factor.

Population differences and genetic variation also matter.

A folate-prevention message should avoid implying that every NTD is preventable.

Early gestational folate status

Risk of a neural tube defect

Supplementation reduces risk

Slide 51 · Population rates differ across geographic settings

Substantial geographic and population variation.

Folate metabolism polymorphisms contribute to some of this variability.

A single unqualified incidence figure would obscure this heterogeneity.

Observed rates vary

Population and geography

Folate-related polymorphisms

Variation is multifactorial, not a single-gene rule

Slide 52 · Folate metabolism genetics modify susceptibility

Polymorphisms in enzymes of folate metabolism are implicated.

Their distribution can help explain population-level differences.

This is not equivalent to one universal Mendelian cause for all neural tube defects.

Observed rates vary

Population and geography

Folate-related polymorphisms

Variation is multifactorial, not a single-gene rule

Slide 53 · DNA methylation is a proposed mechanistic link

The exact mechanism of folate-related risk is not established.

A possible effect on DNA methylation is suggested.

DNA methylation is an epigenetic mechanism involved in gene regulation.

Early gestational folate status

Risk of a neural tube defect

Supplementation reduces risk

Slide 54 · Avoid overstating the folate mechanism

Well established: Folate deficiency is a risk factor.

Observed: Supplementation lowers risk.

Hypothesis: Effects on DNA methylation may be involved.

Unresolved: Precisely how deficiency causes the malformation.

Slide 55 · Recurrence risk in subsequent pregnancies

An overall recurrence rate of 4%–5%.

This is an aggregate estimate across subsequent pregnancies.

Individual circumstances are not resolved by the single textbook percentage.

4–5%

Estimated recurrence in a later pregnancy

Population-level estimate; Not an individual prediction

Slide 56 · Separate recurrence risk from population incidence

A recurrence estimate concerns a later pregnancy after an affected pregnancy.

Geographic or population incidence describes a different denominator.

Combining these measures as if interchangeable leads to false interpretation.

4–5%

Estimated recurrence in a later pregnancy

Population-level estimate; Not an individual prediction

Slide 57 · Case: When should folate risk reduction begin?

A patient plans pregnancy but intends to start supplementation only after a pregnancy test becomes positive.

What feature of neural development makes this timing unreliable?

Examine the structure or clinical clue

Name the lesion and justify why

Slide 58 · Case interpretation: Closure precedes recognition

Neural tube closure is normally complete by approximately day 28.

Many pregnancies are not yet recognized at this stage.

Robbins therefore emphasizes folate availability before conception / throughout reproductive years.

Embryonic development

Early gestation

Day 28:

Closure normally complete

Risk-sensitive window precedes pregnancy recognition

Slide 59 · Case: A child with leg and sphincter deficits

A lumbosacral lesion contains spinal cord tissue. The child has lower-extremity weakness, diminished sensation, and disturbances of bowel and bladder control.

Which named defect best links morphology and clinical features?

Examine the structure or clinical clue

Name the lesion and justify why

Slide 60 · Case interpretation: Myelomeningocele

Cord tissue extends through the vertebral defect: Myelomeningocele.

Lumbosacral location matches the common site.

Lower-limb and pelvic-organ dysfunction are coherent consequences of neural involvement.

Outpouching through skeletal defect

Meninges only

MENINGOCELE

Meninges + cord

MYELOMENINGOCELE

Contents, not external silhouette, determine name

Slide 61 · Case: A clinically silent vertebral anomaly

A structural examination identifies a spinal bony midline defect in an otherwise asymptomatic individual.

Which end of the spinal dysraphism spectrum does this resemble?

Examine the structure or clinical clue

Name the lesion and justify why

Slide 62 · Case interpretation: Spina bifida occulta

A silent bony defect corresponds to the occulta end of the spectrum.

The label does not automatically imply cord extrusion.

Contrast with the severely malformed, disorganized cord in advanced dysraphism.

Spina bifida occulta

Bone defect, no stated symptoms

Meningocele

Meninges extend outward

Myelomeningocele

Cord tissue in lesion

Severe spinal dysraphism

Flattened, disorganized cord

Slide 63 · Final morphologic sorting exercise

Cranial defect + malformed brain: Encephalocele.

Spinal defect + meninges alone: Meningocele.

Spinal defect + cord tissue: Myelomeningocele.

Anterior tube disruption with loss of brain and vault: Anencephaly.

Defect / sac observation

Determine meninges vs neural tissue

Assign precise morphologic term

Slide 64 · Three principles for pathology interpretation

Specify primary tissue or developmental mechanism when known.

Use precise lesion contents to name an extrusion.

Translate morphology into plausible functional effects without guessing an individual outcome.

Slide 65 · Three principles for risk interpretation

Folate deficiency: Established early-gestational risk factor.

Folate supplementation: Preventive benefit depends on timing.

DNA methylation: Plausible mechanism, explicitly uncertain.

Slide 66 · References and source limitations

Robbins, Cotran & Kumar: Pathologic Basis of Disease. 11th ed. (2026). Chapter 28: The Central Nervous System, pp. 1133–1134.

Primary working input: supplied robbins.md and indexed topic extract; extract repaired editorially where adjacent text was interleaved.

The original chapter PDF and its clinical Fig. 28.6 were not available in the supplied materials; conceptual diagrams are native PowerPoint schematics.